Tyra Biosciences, Inc. (TYRA)
NASDAQ · Manufacturing · Pharmaceutical preparations
TYRA price, last 12 months
Key stats
- Previous close
- $22.41
- Open
- $22.50
- Day range
- $21.67 – $22.80
- 52-week range
- $12.40 – $40.65
- Volume
- 720.1K
- Avg volume (20 days)
- 1.4M
- Market cap
- $1.5B
Performance
Technicals and fundamentals
About Tyra Biosciences, Inc.
Tyra Biosciences Inc is a clinical-stage biotechnology company focused on developing next-generation precision medicines for large opportunities in targeted oncology and genetically defined conditions, harnessing the power of Fibroblast Growth Factor Receptor (FGFR) biology. The company's in-house precision medicine platform, SNAP, enables rapid and precise drug design through iterative molecular SNAPshots that help to design and predict which product candidates may demonstrate the highest potency, selectivity, and tolerability in the clinic. The various drug candidates in the company's product pipeline are FGFR3, FGFR4/3, and FGFR1/2/3: three clinical-stage, novel small molecules designed to overcome the toxicity and resistance liabilities of first-generation pan-FGFR inhibitors.
- Sector
- Manufacturing
- Industry
- Pharmaceutical preparations
- Listed on
- NASDAQ
- Market cap
- $1.5B